Hey! I'm Jar — Manvendra's AI sidekick. Want me to show you around?

Healthcare AI

Building AI Products in Healthcare: Lessons from CareBow

Healthcare AI has the highest stakes and the highest fail rate. These are the seven lessons I learned shipping CareBow — a GPT-4 + LangChain symptom triage platform — that I wish I had known on day one.

April 17, 202610 min readUpdated April 25, 2026

Building AI Products in Healthcare: Lessons from CareBow

Healthcare AI is brutal. The data is messy, the regulation is thick, the users are skeptical, and a wrong answer is not a bad UX — it is a clinical event. Here are the lessons from building CareBow, an AI-powered in-home healthcare coordination platform now serving a 1,000+ pre-launch waitlist.

Lesson 1: Ship Coordination, Not Diagnosis

Every healthcare AI founder wants to build a diagnostic engine. Almost none of them ship one. Why? FDA, malpractice exposure, and the bar for clinical-grade evidence is brutal.

What ships: coordination. Triage, routing, scheduling, follow-up, documentation. Tasks where the AI accelerates a human decision rather than replacing it. CareBow does triage and routing — never diagnosis.

Lesson 2: HITL Is Not Optional

Human-in-the-loop is not a quality fallback in healthcare. It is the product. Every CareBow interaction has a defined escalation path: low-acuity self-care guidance, moderate-acuity teleconsult, high-acuity in-home visit, emergency 911 routing. The AI selects the path. A human always reviews high-acuity routes.

Lesson 3: The Eval Set Is the Product

We built CareBow's eval set before we wrote the first agent prompt. 200+ patient scenarios written by clinicians, each labeled with the correct care level. Every prompt change runs against this set. A regression in eval pass rate blocks the deploy. No exceptions.

Lesson 4: Pre-Seed Investors Want Distribution, Not Tech

The pitch that landed our $500K pre-seed conversation was not the model architecture. It was the partnership pipeline: 40+ in-bound leads from clinics, agencies, and provider networks who want to white-label triage. AI is commoditizing fast. Distribution is not.

Lesson 5: Latency Beats Accuracy in Triage

A 95% accurate triage that takes 30 seconds loses to a 90% accurate triage that takes 3 seconds. Patients are anxious, mobile, and one-handed. We hard-cap response time at 4 seconds. Quality optimization happens within that budget, not outside it.

Lesson 6: HIPAA Is a Roadmap Constraint, Not a Compliance Task

HIPAA changes architecture: which models you can use, where data lives, what you log, who sees prompts. Bake it into the roadmap on day one or you will rebuild later.

Lesson 7: The Hardest Part Is Not the AI

It is integration. EHRs, scheduling systems, identity, payment, consent forms, prescription pipes. AI is the surface; plumbing is the iceberg. Budget your engineering accordingly.

Read Next

Frequently Asked

Can AI safely triage patients?

AI can route patients to appropriate care levels with human-in-the-loop oversight. It should not diagnose without clinical review, but it can dramatically accelerate intake, intake routing, and scheduling.

How does CareBow handle HIPAA?

Architecture is HIPAA-aware from day one: regional data residency, BAAs with model providers, structured prompt logging with PHI redaction, and explicit consent flows.

What is the right metric for healthcare AI products?

Care-path accuracy (did the AI route the patient to the correct level of care?) combined with latency and clinician override rate. Engagement alone is misleading in healthcare.

MK

Manvendra Kumar

Senior AI Product Manager · Pittsburgh, PA. Founder of CareBow. 5+ years shipping production AI platforms — LangChain, agentic workflows, 500+ daily claims automated.